Global Kinetics Corporation and uMotif have announced a new partnership to offer a comprehensive, validated and simple to use data capture platform to advance the treatment and understanding of Parkinson’s disease.

Bringing together leading proprietary products, the combined Global Kinetics and uMotif Parkinson’s platform provides a unique means to measure and demonstrate the value of medications, devices and services in Parkinson’s disease, from clinical through to commercial phases of development.

Read more on PR Newswire here.